Citalopram tablets USP — Class II drug recall D-178-2013
Terminated recall by Dr. Reddy's Laboratories, Inc., reported 2013-03-06, distributed nationwide. Chemical Contamination: The product is being recalled due to complaints reporting a strong garlic odor or stro
| Recall number | D-178-2013 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Dr. Reddy's Laboratories, Inc., Bridgewater, NJ, United States |
| Recall initiated | 2012-08-01 |
| Classified | 2013-02-28 |
| Reported by FDA | 2013-03-06 |
| Terminated | 2013-05-24 |
| Distributed | Nationwide (US) |
| Quantity | 27,805 bottles |
| Reason classes | chemical contamination |
| NDC | 55111-0342-30 |
| Lot numbers | 12/13, C201028 |
Product
Citalopram tablets USP, 10mg, 30-count bottle, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Bachupalli, India 502 325, NDC 55111-342-30
Reason for recall
Chemical Contamination: The product is being recalled due to complaints reporting a strong garlic odor or strong chemical smell.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-178-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.